Investment Summary

Exits Gala Biotech

On October 2, 2003, invested in life science company Gala Biotech from Mason Wells and Advantage Capital Partners for 16M USD

Investment Highlights
  • This is transaction in the Life Science sector.
  • This is largest (disclosed) transaction.
  • This is transaction in the United States.
  • This is transaction in Wisconsin.

Investment Summary

Date 2003-10-02
Target Gala Biotech
Sector Life Science
Sellers(s) Mason Wells
Advantage Capital Partners
Deal Type Trade Sale - Public Company
Deal Value 16M USD

Target

Gala Biotech

Middleton, Wisconsin, United States
website
Gala Biotech, Inc. has developed enabling technology for the production of pharmaceutical proteins. The company's Transgametic technology introduces reengineered retrovectors to cattle to create transgenic embryos that ultimately result in cows that express the desired protein in their milk.

Search 177,782 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 2

SELLER

Mason Wells

Milwaukee, Wisconsin, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1998
PE ASSETS 600M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Mason Wells is a private equity firm focused on middle-market buyout opportunities in the Midwest US. Mason Wells looks to invest in businesses operating in engineered products and services, outsourced business services, and specialty packaging. Target companies typically generate revenue of $25 to $300 million and EBITDA of at least $5 million. The Firm prefers businesses with high barriers to entry, limited customer concentration, and strong market positions. Mason Wells was originally formed 1982 as a subsidiary of Marshall & Ilsley Corporation and became an independent firm in 1998. Mason Wells is based in Milwaukee, Wisconsin.


DEAL STATS #
Overall 10 of 39
Sector (Life Science) 1 of 1
Type (Trade Sale - Public Company) 2 of 11
State (Wisconsin) 8 of 21
Country (United States) 9 of 37
Year (2003) 2 of 2
Size (of disclosed) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-07-02 Eder Industries

Oak Creek, Wisconsin, United States

Eder Industries is a Electronic Manufacturing Services (EMS), focused on manufacturing complex electronic assemblies for Original Equipment Manufacturers (OEM’s).

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-12-01 ZyStor Therapeutics

Milwaukee, Wisconsin, United States

ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs). ZyStor employs a novel, proprietary technology which improves the delivery of therapeutics that replace the missing lysosomal enzyme in LSD patients. ZyStor has demonstrated in cell culture and in a well-characterized animal model that this technology provides several distinct advantages over other LSD therapeutics in use today.

Buy -
SELLER

Advantage Capital Partners

New Orleans, Louisiana, United States

Investor Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 1992
PE ASSETS 2.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.


DEAL STATS #
Overall 5 of 94
Sector (Life Science) 1 of 6
Type (Trade Sale - Public Company) 3 of 13
State (Wisconsin) 1 of 6
Country (United States) 5 of 94
Year (2003) 1 of 1
Size (of disclosed) 10 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-06-01 Emageon

Birmingham,, Alabama, United States

Emageon, Inc. provides information technology systems for hospitals, healthcare networks, and imaging facilities in the United States. The company offers IT solutions to manage medical image storage and distribution, provider radiology, cardiology and visualization, and manage workflow and medical content management.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-10-08 Monarch Machine Tool

Cortland, New York, United States

Monarch Machine Tool is a provider of electronic machines intended to offer metal-cutting equipment. Monarch Machine Tool was established in 1909 and is based in Cortland, New York.

Buy $4M